Expert Review of Clinical Immunology

Article	Citations
Full consideration of the pollen exposure effect in clinical trial design for pollen-induced allergic rhinitis	95
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	88
How could our genetics impact COVID-19 vaccine response?	76
Pepsin, trypsin, and MUC5B are independent risk factors for hearing impairment in patients with laryngopharyngeal reflux-related chronic secretory otitis media	72
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	70
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	57
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review	55
A critical review of dupilumab for adult patients with prurigo nodularis	46
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	43
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	40
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	36
Immunobiology and treatment of cutaneous T-cell lymphoma	36
Bimekizumab for the treatment of psoriatic arthritis	34
Bradford Hill and breast implant illness: no evidence for causal association with breast implants	32
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	32
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	31
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	29
Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis	28
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	28
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	24
How to and should we target EBV in MS?	24
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	24
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	23
Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	23
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19	22

Food immunotherapy: current status and future needs	22
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis	22
Current treatment options and long-term outcomes in patients with eosinophilic esophagitis	21
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps	21
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives	20
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults	19
How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	19
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update	19
Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study	18
Rare forms of inflammatory myopathies – part I, generalized forms	18
Emergence of an adaptive immune paradigm to explain celiac disease: a perspective on new evidence and implications for future interventions and diagnosis	18
Durability and long-term outcomes of biologic therapies in psoriasis	18
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications	18
Pathophysiology and management of Staphylococcus aureus in nasal polyp disease	17
Gut immune homeostasis: the immunomodulatory role of Bacillus clausii, from basic to clinical evidence	17
Neurological adverse effects of chimeric antigen receptor T-cell therapy	17
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors	16
Inflammatory myopathy in adults, health-related quality of life, and wellbeing: a round trip between immune disease and wellness	16
T-lymphocyte depleted transplants for inborn errors of immunity	16
The role of interleukins in pathogenesis and prognosis of atrial fibrillation	16
Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?	15
Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies	15
An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia	15
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategies	15
Recent insights into comorbidities in atopic dermatitis	15
Eradicating measurable residual disease via immunotherapy to cure acute lymphoblastic leukemia: current status and future directions	15
Personalization of therapy for patients with eosinophilic esophagitis	14
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity	14
Challenges in uncontrolled asthma in pediatrics: important considerations for the clinician	14
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management	14
The functional role and the clinical application of periostin in chronic rhinosinusitis	14
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions	14
Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events	13
Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success	13
Insights into the immunological links between dietary habits and asthma	13
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency	13
Patient-centered approaches for patients with systemic autoimmune rheumatic diseases: development and evolution	13
Glucocorticoid in systemic lupus erythematosus: the art beyond science	13
Advances in tumor immunotherapy targeting macrophages	13
Diagnostic accuracy of QuantiFERON-TB gold plus with chemiluminescence immunoassay: a systematic review and meta-analysis	13
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation	13
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis	13
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials	12
Immunology and targeted therapy in Castleman disease	12
Toward a personalized therapy of still’s disease based on immunologic endotypes: a narrative review	12
At the cutting-edge: what’s the latest in imaging to diagnose Sjögren’s disease?	12
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies	12
What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?	12
Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends	12
Monoclonal antibodies in diabetic retinopathy	12

Guidance for stem cell therapy for juvenile systemic sclerosis patients	12
Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis	12
Updates in toxicities associated with immune checkpoint inhibitors	12
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases	12
Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts	11
The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis	11
The interaction between innate immunity and oral microbiota in oral diseases	11
How does sleep influence asthma through immunity?	11
Comparing available JAK inhibitors for treating patients with psoriasis	11
Basophil activation test in the food allergy clinic: its current use and future applications	11
Induction of aquaporins by plasma of patients with systemic lupus erythematosus	11
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine	11
Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics	11
Pediatric IgG4-related disease: a descriptive review	10
Dysautonomia in systemic lupus erythematosus: when to suspect and how to investigate	10
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience	10
A review of disease burden and clinical management for generalized pustular psoriasis in China	10
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors	10
Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review	10
Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects	10
Update on virus-induced asthma exacerbations	10
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy	10
B cell depletion and inhibition in systemic lupus erythematosus	10
Individual differences in response to dust-mite-allergen specific immunotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials	10
An update on VEXAS syndrome	10
Role of tight junction proteins in shaping the immune milieu of malignancies	9
Model-based computational precision medicine to develop combination therapies for autoimmune diseases	9
The relationship between interleukin 17A rs2275913 gene polymorphism and circulating IL17A levels and disease activity and severity in Egyptian rheumatoid arthritis patients	9
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications	9
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge	9
Tofacitinib for the treatment of active ankylosing spondylitis in adults	9
An evaluation of anifrolumab for use in adults with systemic lupus erythematosus	9
Vascular endothelial dysfunction in pediatric rheumatic diseases: a systematic review and meta-analysis	9
The clinical role of anakinra in the armamentarium against familial Mediterranean fever	9
How suitable is intravenous tocilizumab for the treatment of Graves’ ophthalmopathy?	9
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation	9
Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease	9
Risk of infections in psoriasis: assessment and challenges in daily management	9
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies	9
Management and treatment optimization of patients with mild to moderate ulcerative colitis	8
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective	8
AQP9 weakens the cytotoxicity of CD8 + T cells in colon adenocarcinoma by boosting M2 polarization of macrophages under hypoxia conditions	8
The role of systemic corticosteroids in severe asthma and new evidence in their management and tapering	8
The suitability of treating atopic dermatitis with Janus kinase inhibitors	8
Evaluating the role of lung ultrasound in the diagnosis of rheumatoid arthritis-interstitial lung disease	8
Potential interactions between STING pathway and the complement system in immune regulation	8
Considerations for managing elderly patients with atopic dermatitis	8
Early diagnosis of systemic sclerosis, where do we stand today?	8
The role of PCSK9 in inflammation, immunity, and autoimmune diseases	8
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives	8
Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options	8
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population	8
A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease	8
Response to letter to the editor: Bradford Hill and breast implant illness: evidence for a causal association with breast implants	8
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges	8
Mechanisms and therapeutic potential of epithelial-immune crosstalk in airway inflammation	8
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons	8
The emerging role of IL-23 in asthma and its clinical implications	8
The (apparent) antibody paradox in COVID-19	8
Enthesitis-related arthritis and spondylarthritis: the same disease or disparate entities?	8
Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies	8
Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease	8
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update	8
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults	8
Biomarkers for systemic lupus erythematosus – a focus on organ damage	8
Systemic therapy in juvenile localized scleroderma	8
Clinical and immunologic implication of neo-osteogenesis in chronic rhinosinusitis	8
TBXAS1 deficiency: a novel monogenic cause of chronic nonbacterial osteomyelitis responsive to COX inhibitors	7
Cytokine alterations in psoriasis: an updated review	7
The burden of mental health issues in Behçet’s disease: implications for patient quality of life	7
Decoding T and B cell dynamics in inborn errors of immunity: insights into immune dysfunction	7
Is post-COVID syndrome an autoimmune disease?	7
Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis	7
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency	7
Comorbid allergic rhinitis and asthma: important clinical considerations	7
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients	7
The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review	7
The pathophysiology of MASLD: an immunometabolic perspective	7
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?	7
Comparative efficacy of systemic treatments for atopic dermatitis in adults	7

Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature	7
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review	7
Development of a method of nasal secretions sampling for local nasal inflammation studies	7
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis	7
Colchicine: protection of the brain beyond the heart?	7
Unmet needs in the management of giant cell arteritis and polymyalgia rheumatica	7
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens	6
An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis	6
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis	6
Thyroid eye disease in the biologic era: a 40-year paradigm shift in nonsurgical therapeutic strategies	6
IL-10: the master immunomodulatory cytokine in allergen immunotherapy	6
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments	6
A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps	6
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease	6
What is the full potential of baricitinib in treating patients with COVID-19?	6
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic	6
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis	6
Managing acute COVID-19 in immunocompromised pediatric patients	6
Re-envisioning clinical trial design in systemic sclerosis	6
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease	6
Correction	6
Growth differentiation factor-15 as an emerging biomarker for identifying myositis	6
Recent issues in JAK inhibitor safety: perspective for the clinician	6
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome	6
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps	6
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus	6
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy	5
Avacopan for the treatment of ANCA-associated vasculitis: an update	5
Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults	5
New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis	5
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum aut	5
Exploring treatment options for pediatric refractory chronic urticaria	5
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis	5
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours	5
Personalizing therapy selection in inflammatory bowel disease	5
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial	5
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study	5
The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders	5
Exploring the relationship between house dust mites and asthma	5
Linking stress and inflammation – is there a missing piece in the puzzle?	5
Innovative surgical approaches for chronic rhinitis: nasal neurectomy mechanisms, techniques, and clinical outcomes	5
The oft-overlooked cardiovascular complications of inflammatory bowel disease	5
Recent insights into the impacts of COVID-19 on pediatric asthma	5
Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions	5
Probiotics in asthma management: fiction or truth?	5
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy	5
Preventing fibrosis in IBD: update on immune pathways and clinical strategies	5
Single-cell RNA sequencing: an emerging tool revealing dysregulated innate and adaptive immune response at single cell level in Kawasaki disease	5
Biologics for chronic spontaneous urticaria: toward a personalized treatment	5
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition	5
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus	5
Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology	5
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?	5
Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis	5
The complex relationship between large granular lymphocyte leukemia and rheumatic disease	4
Diagnostic methods and strategies for autoimmune bullous diseases	4
Can we identify patients at risk of severe reactions to food?	4
Causal role of immune cells in chronic obstructive pulmonary disease: Mendelian randomization study	4
Precision medicine in chronic rhinosinusitis – using endotype and endotype-driven therapeutic options	4
Secukinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients aged six years and older	4
IgG4-related disease: advances in pathophysiology and treatment	4
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making	4
A review of berotralstat for the treatment of hereditary angioedema	4
An update on biologic treatments for neuromyelitis optica spectrum disorder	4
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis	4
Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review	4
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)	4
Association between inactivated COVID-19 vaccine and semen quality among males recovered from omicron infection: a retrospective cohort study	4
The role of nasal cytology in the diagnosis and treatment of Allergic rhinitis	4
Translational impact of omics studies in alopecia areata: recent advances and future perspectives	4
Why do drug treatments fail in Sjögren’s disease? Considerations for treatment, trial design and interpretation of clinical efficacy	4
Ruxolitinib cream for the short-term treatment of mild-moderate atopic dermatitis	4
Topical roflumilast for the treatment of psoriasis	4
Combination immunotherapy for pancreatic cancer: challenges and future considerations	4
Gut inflammation in CVID: causes and consequences	4
Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease	4
Chronic rhinosinusitis disease control: a review of the history and the evidence	4
Comparing treatment options for large vessel vasculitis	4
Spectrum of neurological manifestations, existence of diabetes mellitus, and 5-year mortality and cancer association outcomes in a cohort of Omani patients with positive anti- GAD autoimmunity	4
Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review	4
Breast implant illness: scientific evidence of its existence	4
Periostin as a biomarker of severity and mortality in COVID-19 patients	4
Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression	4
Do JAK inhibitors have a realistic future in treating Crohn’s disease?	4
Upadacitinib for moderate-to-severe atopic dermatitis, in adults and adolescents 12 years and older: review of international and Japanese populations	4
Behçet disease: epidemiology, classification criteria and treatment modalities	4
Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis	4
Genes vs environment in inflammatory bowel disease: an update	4
Diagnosis and management of systemic sclerosis-related calcinosis	4
Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease	3
Immunology of atherosclerosis as an inflammatory disease: rethinking the dynamic immunoinflammatory activity beneath stability	3
Allergen immunotherapy: progress and future outlook	3
Decoding autoimmune bullous diseases from single-cell RNA-seq and future directions	3
Patch testing while immunosuppressed: potential risks and benefits	3
Immune signatures, testing, and management of febrile neutropenia in pediatric cancer patients	3